BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 95 filers reported holding BIOXCEL THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.94 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $746,400 | -30.5% | 40,000 | -20.0% | 0.52% | -51.5% |
| Q4 2022 | $1,074,000 | +81.7% | 50,000 | 0.0% | 1.06% | +75.1% |
| Q3 2022 | $591,000 | -41.9% | 50,000 | 0.0% | 0.61% | +104.7% |
| Q4 2021 | $1,017,000 | -4.2% | 50,000 | +42.9% | 0.30% | +9.6% |
| Q3 2021 | $1,062,000 | +46.1% | 35,000 | +40.0% | 0.27% | +37.1% |
| Q2 2021 | $727,000 | -32.6% | 25,000 | 0.0% | 0.20% | -45.9% |
| Q1 2021 | $1,079,000 | -6.6% | 25,000 | 0.0% | 0.36% | -24.5% |
| Q4 2020 | $1,155,000 | +33.2% | 25,000 | +25.0% | 0.48% | +14.8% |
| Q3 2020 | $867,000 | -34.6% | 20,000 | -20.0% | 0.42% | -43.8% |
| Q2 2020 | $1,325,000 | – | 25,000 | – | 0.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 430,000 | $19,866,000 | 1.70% |
| APIS CAPITAL ADVISORS, LLC | 20,000 | $924,000 | 0.89% |
| Avidity Partners Management LP | 547,000 | $25,271,000 | 0.82% |
| Knoll Capital Management, LLC | 20,000 | $924,000 | 0.63% |
| Artemis Investment Management LLP | 1,013,448 | $46,839,000 | 0.49% |
| AlphaCentric Advisors LLC | 25,000 | $1,155,000 | 0.48% |
| First Light Asset Management, LLC | 94,202 | $4,352,000 | 0.32% |
| Ikarian Capital, LLC | 150,000 | $6,930,000 | 0.31% |
| Longitude (Cayman) Ltd. | 8,000 | $370,000 | 0.18% |
| AllSquare Wealth Management LLC | 5,490 | $254,000 | 0.17% |